180 related articles for article (PubMed ID: 11141484)
1. Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1.
Ploplis VA; Cornelissen I; Sandoval-Cooper MJ; Weeks L; Noria FA; Castellino FJ
Am J Pathol; 2001 Jan; 158(1):107-17. PubMed ID: 11141484
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of neointima formation following arterial injury in PAI-1 deficient mice.
Ploplis VA; Castellino FJ
Ann N Y Acad Sci; 2001; 936():466-8. PubMed ID: 11460504
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice.
Zhu Y; Farrehi PM; Fay WP
Circulation; 2001 Jun; 103(25):3105-10. PubMed ID: 11425776
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries.
DeYoung MB; Tom C; Dichek DA
Circulation; 2001 Oct; 104(16):1972-1. PubMed ID: 11602503
[TBL] [Abstract][Full Text] [Related]
5. Endogenous vitronectin and plasminogen activator inhibitor-1 promote neointima formation in murine carotid arteries.
Peng L; Bhatia N; Parker AC; Zhu Y; Fay WP
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):934-9. PubMed ID: 12067901
[TBL] [Abstract][Full Text] [Related]
6. Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator.
Schäfer K; Konstantinides S; Riedel C; Thinnes T; Müller K; Dellas C; Hasenfuss G; Loskutoff DJ
Circulation; 2002 Oct; 106(14):1847-52. PubMed ID: 12356640
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation.
Moura R; Tjwa M; Vandervoort P; Cludts K; Hoylaerts MF
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2163-9. PubMed ID: 17761938
[TBL] [Abstract][Full Text] [Related]
8. Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1.
Sjöland H; Eitzman DT; Gordon D; Westrick R; Nabel EG; Ginsburg D
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):846-52. PubMed ID: 10712412
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 from bone marrow-derived cells suppresses neointimal formation after vascular injury in mice.
Schäfer K; Schroeter MR; Dellas C; Puls M; Nitsche M; Weiss E; Hasenfuss G; Konstantinides SV
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1254-9. PubMed ID: 16514083
[TBL] [Abstract][Full Text] [Related]
10. Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1).
Lijnen HR; Van Hoef B; Umans K; Collen D
J Thromb Haemost; 2004 Jan; 2(1):16-22. PubMed ID: 14717961
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice.
Konstantinides S; Schäfer K; Thinnes T; Loskutoff DJ
Circulation; 2001 Jan; 103(4):576-83. PubMed ID: 11157725
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1).
Schneider DJ; Hayes M; Wadsworth M; Taatjes H; Rincón M; Taatjes DJ; Sobel BE
J Histochem Cytochem; 2004 Aug; 52(8):1091-9. PubMed ID: 15258185
[TBL] [Abstract][Full Text] [Related]
13. Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1.
Schafer K; Müller K; Hecke A; Mounier E; Goebel J; Loskutoff DJ; Konstantinides S
Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2097-103. PubMed ID: 14512369
[TBL] [Abstract][Full Text] [Related]
14. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.
Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ
Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781
[TBL] [Abstract][Full Text] [Related]
15. Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation.
Zhang LN; Wilson DW; da Cunha V; Sullivan ME; Vergona R; Rutledge JC; Wang YX
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):765-72. PubMed ID: 16456092
[TBL] [Abstract][Full Text] [Related]
16. The role of fibrinolytic genes and proteins in the development of allograft vascular disease.
Benza RL; Passineau MJ; Anderson PG; Barchue JP; George JF
J Heart Lung Transplant; 2011 Aug; 30(8):935-44. PubMed ID: 21652221
[TBL] [Abstract][Full Text] [Related]
17. A DNA enzyme against plasminogen activator inhibitor- type 1 (PAI-1) limits neointima formation after angioplasty in an obese diabetic rodent model.
Witkowski P; Seki T; Xiang G; Martens T; Sondermeijer H; See F; Bhagat G; Schuster M; Hardy MA; Itescu S
J Cardiovasc Pharmacol; 2007 Dec; 50(6):633-40. PubMed ID: 18091579
[TBL] [Abstract][Full Text] [Related]
18. C-type natriuretic peptide (CNP) suppresses plasminogen activator inhibitor-1 (PAI-1) in vivo.
Kairuz EM; Barber MN; Anderson CR; Kanagasundaram M; Drummond GR; Woods RL
Cardiovasc Res; 2005 Jun; 66(3):574-82. PubMed ID: 15914122
[TBL] [Abstract][Full Text] [Related]
19. Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice.
Chan JC; Duszczyszyn DA; Castellino FJ; Ploplis VA
Am J Pathol; 2001 Nov; 159(5):1681-8. PubMed ID: 11696429
[TBL] [Abstract][Full Text] [Related]
20. Maladaptive arterial remodeling with systemic hypertension associated with increased concentrations in blood of plasminogen activator inhibitor type-1 (PAI-1).
Furumoto T; Fujii S; Nishihara K; Yamada S; Komuro K; Goto K; Onozuka H; Mikami T; Kitabatake A; Sobel BE
Am J Cardiol; 2004 Apr; 93(8):997-1001. PubMed ID: 15081442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
